284 related articles for article (PubMed ID: 7815346)
1. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
Welch SP; Thomas C; Patrick GS
J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
Welch SP; Stevens DL
J Pharmacol Exp Ther; 1992 Jul; 262(1):10-8. PubMed ID: 1320680
[TBL] [Abstract][Full Text] [Related]
3. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
Welch SP; Dunlow LD
J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
[TBL] [Abstract][Full Text] [Related]
5. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
Pugh G; Smith PB; Dombrowski DS; Welch SP
J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163
[TBL] [Abstract][Full Text] [Related]
6. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
7. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
Welch SP; Stevens DL; Dewey WL
J Pharmacol Exp Ther; 1992 Jan; 260(1):117-27. PubMed ID: 1346158
[TBL] [Abstract][Full Text] [Related]
8. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
Lichtman AH; Cook SA; Martin BR
J Pharmacol Exp Ther; 1996 Feb; 276(2):585-93. PubMed ID: 8632325
[TBL] [Abstract][Full Text] [Related]
9. Spinal morphine/clonidine antinociceptive synergism: involvement of G proteins and N-type voltage-dependent calcium channels.
Wei ZY; Karim F; Roerig SC
J Pharmacol Exp Ther; 1996 Sep; 278(3):1392-407. PubMed ID: 8819527
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
11. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
13. Spinal and supraspinal components of cannabinoid-induced antinociception.
Lichtman AH; Martin BR
J Pharmacol Exp Ther; 1991 Aug; 258(2):517-23. PubMed ID: 1650831
[TBL] [Abstract][Full Text] [Related]
14. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
15. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.
Pugh G; Mason DJ; Combs V; Welch SP
J Pharmacol Exp Ther; 1997 May; 281(2):730-7. PubMed ID: 9152379
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse.
Xu JY; Tseng LF
J Pharmacol Exp Ther; 1995 Jul; 274(1):8-16. PubMed ID: 7616452
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
Solomon RE; Gebhart GF
J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
[TBL] [Abstract][Full Text] [Related]
18. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
Lux F; Welch SP; Brase DA; Dewey WL
J Pharmacol Exp Ther; 1988 Aug; 246(2):500-7. PubMed ID: 3136242
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive action of myricitrin: involvement of the K+ and Ca2+ channels.
Meotti FC; Fachinetto R; Maffi LC; Missau FC; Pizzolatti MG; Rocha JB; Santos AR
Eur J Pharmacol; 2007 Jul; 567(3):198-205. PubMed ID: 17467689
[TBL] [Abstract][Full Text] [Related]
20. Spinal antinociception of synthetic omega-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium channel blocker, and its effects on morphine analgesia in chemical stimulus tests in rodent.
Yan LD; Liu YL; Zhang L; Dong HJ; Zhou PL; Su RB; Gong ZH; Huang PT
Eur J Pharmacol; 2010 Jun; 636(1-3):73-81. PubMed ID: 20361956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]